APA (7th ed.) Citation

Maierthaler, M., Kriegsmann, M., Peng, C., Jauch, S., Szabo, A., Wallwiener, M., . . . Burwinkel, B. (2015). S100P and HYAL2 as prognostic markers for patients with triple-negative breast cancer. Experimental and molecular pathology, 99(1), . https://doi.org/10.1016/j.yexmp.2015.06.010

Chicago Style (17th ed.) Citation

Maierthaler, Melanie, et al. "S100P and HYAL2 as Prognostic Markers for Patients with Triple-negative Breast Cancer." Experimental and Molecular Pathology 99, no. 1 (2015). https://doi.org/10.1016/j.yexmp.2015.06.010.

MLA (9th ed.) Citation

Maierthaler, Melanie, et al. "S100P and HYAL2 as Prognostic Markers for Patients with Triple-negative Breast Cancer." Experimental and Molecular Pathology, vol. 99, no. 1, 2015, https://doi.org/10.1016/j.yexmp.2015.06.010.